(NP (NP (NP (NN Regulation)) (PP (IN of) (NP (NN interleukin-1) (NN beta) (NN production))) (PP (IN by) (NP (NNS glucocorticoids))) (PP (IN in) (NP (JJ human) (NNS monocytes))) (: :)) (S (NP-SBJ (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN action)))) (VP (VBZ depends) (PP (IN on) (NP (DT the) (NN activation) (NN signal)))) (. .)))
(S (NP-SBJ-1 (NNS Glucocorticoids)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB downregulate) (NP (NP (NN interleukin-1) (NN beta) (NN production)) (PP (IN in) (NP (JJ monocytic) (NNS cells)))) (PP (IN by) (NP (NP (CD two) (JJ different) (NNS mechanims)) (: :) (NP-COOD (NP (NP (JJ direct) (NN inhibition)) (PP (IN of) (NP (DT the) (NN gene) (NN transcription)))) (CC and) (NP (NP (NN destabilization)) (PP (IN of) (NP (DT the) (JJ preformed) (NN interleukin-1) (NN beta) (NN mRNA)))))))))))) (. .))
(S (ADVP-TMP (RB Now)) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (DT the) (NN monocyte) (NN activating) (NN signal))))) (PP (IN on) (NP (DT these) (CD two) (JJ inhibitory) (NNS mechanims)))))) (. .))
(S (SBAR-TMP (WHADVP-100 (WRB When)) (S (NP-SBJ-10 (JJ human) (NNS monocytes)) (VP (VBD were) (VP-COOD (VP (VBN preincubated) (NP (-NONE- *-10)) (PP (IN with) (NP (NN dexamethasone))) (PP-TMP (IN for) (NP (CD 1) (NN hour))) (ADVP (-NONE- *T*-100))) (CC and) (RB then) (VP (VBN stimulated) (NP (-NONE- *-10)) (PP (CC either) (IN with) (NP-COOD (NP (JJ bacterial) (NN lipopolysaccharide)) (CC or) (NP (NN phorbol) (NN myristate)))) (ADVP (-NONE- *T*-100))))))) (, ,) (NP-SBJ (PRP it)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S-COOD (S (NP-SBJ (NN dexamethasone)) (VP (VBD inhibited) (NP (DT the) (JJ lipopolysaccharide-induced) (NN interleukin-1) (NN beta) (NN protein) (NN production)))) (, ,) (CC but) (S (NP-SBJ-3 (DT the) (ADJP (NN phorbol) (JJ myristate-induced)) (NN production)) (VP (VBD was) (VP (VBN increased) (NP (-NONE- *-3)) (NP (QP (CD 3-10)) (RB fold))))))))) (. .))
(S (NP-SBJ-2 (DT This) (NN difference)) (VP (VBD was) (ADVP (RB also)) (VP (VBN seen) (NP (-NONE- *-2)) (PP (IN at) (NP (DT the) (NN mRNA) (NN level))))) (. .))
(S (SBAR-TMP (WHADVP-101 (WRB When)) (S (NP-SBJ-4 (NN dexamethasone)) (VP (VBD was) (VP (VBN added) (NP (-NONE- *-4)) (PP (TO to) (NP (DT the) (NNS cultures))) (PP-TMP (NP (CD 3) (NNS hours)) (IN after) (NP (DT the) (NNS stimulators))) (ADVP (-NONE- *T*-101)))))) (, ,) (NP-SBJ (PRP it)) (ADVP (RB clearly)) (VP (VBD decreased) (NP (DT the) (NN interleukin-1) (NN beta) (NN mRNA) (NNS levels)) (ADVP (RB regardless) (PP (IN of) (NP (NP (DT the) (NN stimulator)) (VP (VBN used) (NP (-NONE- *)))))) (-LRB- -LRB-) (SBAR (IN although) (S (NP-SBJ (DT the) (NN effect)) (VP (VBD was) (ADJP-PRD (RB clearly) (JJR weaker)) (PP (IN on) (NP (DT the) (JJ PMA-induced) (NN mRNA)))))) (-RRB- -RRB-)) (. .))
(S (ADVP (RB Thus)) (NP-SBJ (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S-COOD (S (NP-SBJ-5 (NP (DT the) (ADJP (NN phorbol) (JJ myristate-induced)) (NN signal)) (PRN (-LRB- -LRB-) (FRAG (NP (JJ prolonged) (NN protein) (NN kinase) (NN C) (NN activation)) (. ?)) (-RRB- -RRB-))) (VP (MD can) (RB not) (VP (VB be) (VP (VBN inhibited) (NP (-NONE- *-5)) (PP (IN by) (NP-LGS (NP (JJ prior) (NN incubation)) (PP (IN with) (NP (NN dexamethasone))))))))) (CC and) (S (NP-SBJ (PRP it)) (ADVP (RB also)) (VP (VBZ protects) (NP (DT the) (VBN induced) (NN mRNA)) (PP (IN for) (NP (NP (DT the) (JJ degradative) (NN action)) (PP (IN of) (NP (NN dexamethasone)))))))))) (. .))
